semaglutide .25 mg not working Medscape | The FDA has approved once-daily oral 25 (Wegovy Pill, Novo Nordisk) as the first GLP-1 agonist pill for weight management. ⁠ The letter cited three deaths

Your primary care physician can provide general guidance and support for weight loss, including recommendations for diet and exercise

Releases WADAs 2026 Prohibited List is now in force The World Anti-Doping Agency (WADA) wishes to remind stakeholders that the 2026 List of Prohibited Substances and Methods (List) and the 2026 Monitoring Program are now in force as of today (1 January 2026)

For example, Mounjaro is approved to treat Type 2 diabetes, but it also reduces appetite

Now, let's talk about the elephant in the room: weight loss myths

Tirzepatide May NOT Be Ideal If: You only need mild appetite control You are seeking cosmetic or short-term weight loss You have contraindicated medical conditions You are not under professional medical supervision This injection is not meant for minor weight loss (57 kg) Key Differences Between Semaglutide and Tirzepatide Both Injections Offer These Key Benefits Semaglutide and Tirzepatide are doctor-approved weight-loss injections that have been thoroughly researched for safety and effectiveness

I've been talking so highly of Dr